Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2

Abstract

Both phase 0 and phase II NF2 trials are near-term options for NF2 clinical trials. The number of NF2 patients in the population remains limited, and successful recruitment will require ongoing collaboration efforts between NF2 clinics.